Zaklina Buljovcic, Pharmalex GmbH, Director Scientific Services, Principal Consultant Innovative Therapies.
She is a biologist by training and holds a PhD in Natural Sciences. She started her professional career in F&E at a small Biotech Company in Heidelberg, Germany in 2000 and joined PharmaLex in 2004. At PharmaLex she held various positions and established different kind of product groups focusing e.g. on tissue preperations, herbal or veterinary products. Since 2008 she is working at PharmaLex as project manager on various ATMP products supporting mainly SME Biotech Companies. This is including strategic regulatory support, preperation of national and EU Scientific Advices, preperation of IMPDs, as well as dossieres for hospital exemption in Germany and EU Centralized Procedures. She is also one of the leading regulatory experts in Germany for ATMPs, giving regularly lectures on various ATMP-topics and engaging in joint industry / health authority working groups.